Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 2
1997 2
1998 1
1999 2
2002 3
2004 1
2008 1
2009 7
2010 4
2011 4
2012 3
2013 2
2014 1
2015 1
2016 2
2017 1
2018 1
2020 1
2022 1
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Riociguat for the treatment of pulmonary arterial hypertension.
Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group. Ghofrani HA, et al. N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655. N Engl J Med. 2013. PMID: 23883378 Free article. Clinical Trial.
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.
Couturaud F, Schmidt J, Sanchez O, Ballerie A, Sevestre MA, Meneveau N, Bertoletti L, Connault J, Benhamou Y, Constans J, Quemeneur T, Lapébie FX, Pernod G, Picart G, Elias A, Doutrelon C, Neveux C, Khider L, Roy PM, Zuily S, Falvo N, Lacroix P, Emmerich J, Mahé I, Boileau J, Yaici A, Le Jeune S, Stéphan D, Plissonneau-Duquene P, Ray V, des Déserts MD, Belhadj-Chaidi R, Lamia B, Gruel Y, Presles E, Girard P, Tromeur C, Moustafa F, Rothstein V, Lacut K, Melac S, Barillot S, Mismetti P, Laporte S, Mottier D, Meyer G, Leroyer C; RENOVE Investigators. Couturaud F, et al. Lancet. 2025 Mar 1;405(10480):725-735. doi: 10.1016/S0140-6736(24)02842-3. Lancet. 2025. PMID: 40023651 Free article. Clinical Trial.
[Stop bacterial resistance: save antibiotics].
Carlet J; le groupe Alliance francophone contre le développement des bactéries multi-résistantes aux antibiotiques (AC-2-BMR). Carlet J, et al. Med Mal Infect. 2011 Jul;41(7):351-2. doi: 10.1016/j.medmal.2011.06.003. Epub 2011 Jul 20. Med Mal Infect. 2011. PMID: 21764235 French. No abstract available.
[Follow-up strategies for lung transplant recipients in France].
Dégot T, Douvry B, Falque L, Bautin N, Frachon I, Mankikian J, Le Pavec J, Picard C; Groupe de travail de transplantation pulmonaire de la société de pneumologie de langue française (SPLF). Dégot T, et al. Among authors: frachon i. Rev Mal Respir. 2023 Apr;40(4):314-323. doi: 10.1016/j.rmr.2023.01.024. Epub 2023 Mar 1. Rev Mal Respir. 2023. PMID: 36868975 Review. French.
Update on the roles of distal airways in asthma.
Burgel PR, de Blic J, Chanez P, Delacourt C, Devillier P, Didier A, Dubus JC, Frachon I, Garcia G, Humbert M, Laurent F, Louis R, Magnan A, Mahut B, Perez T, Roche N, Tillie-Leblond I, Tunon de Lara M, Dusser D. Burgel PR, et al. Among authors: frachon i. Eur Respir Rev. 2009 Jun;18(112):80-95. doi: 10.1183/09059180.00001109. Eur Respir Rev. 2009. PMID: 20956128 Free article. Review.
Tough ruling for Servier in the Mediator trial.
Frachon I, Benkimoun P. Frachon I, et al. Lancet. 2024 Mar 30;403(10433):1235-1236. doi: 10.1016/S0140-6736(24)00154-5. Lancet. 2024. PMID: 38555126 No abstract available.
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.
Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H. Gallot G, et al. Among authors: frachon i. J Immunother. 2014 Apr;37(3):170-9. doi: 10.1097/CJI.0000000000000031. J Immunother. 2014. PMID: 24598452 Clinical Trial.
44 results